ProCE Banner Activity

Educating Patients on Reducing Their Risk for CDI Recurrence

Clinical Thought

Patients undergoing treatment for CDI often ask, “What is my risk for the infection coming back and how can I prevent it?” Read my commentary on how to identify individual patient risks for recurrence and strategies—both current and future—to prevent recurrent CDI.

Released: March 23, 2023

Share

Faculty

Carolyn D. Alsonso

Carolyn D. Alsonso, MD

Assistant Professor of Medicine
Division of Infectious Diseases
Department of Medicine
Harvard Medical School
Director
Transplant & Immunocompromised Host ID Program
Division of Infectious Diseases
Beth Israel Deaconess Medical Center
Boston, Massachusetts

Provided by

ProCE Banner

Supporters

Merck Sharp & Dohme Corp.

Partners

Peggy Lillis Foundation

ProCE Banner

Faculty Disclosure

Primary Author

Carolyn D. Alsonso, MD

Assistant Professor of Medicine
Division of Infectious Diseases
Department of Medicine
Harvard Medical School
Director
Transplant & Immunocompromised Host ID Program
Division of Infectious Diseases
Beth Israel Deaconess Medical Center
Boston, Massachusetts

Carolyn D. Alonso, MD: consultant/advisor/speaker: AiCuris, Cidara, Merck; researcher: Merck.